Literature DB >> 15942195

The SRC-induced mesenchymal state in late-stage colon cancer cells.

Egle Avizienyte1, Valerie G Brunton, Valerie J Fincham, Margaret C Frame.   

Abstract

One major function of elevated Src kinase in epithelial cancer cells is to drive adhesion changes that are associated with the mesenchymal transition and metastasis. Here we review recent work that describes Src-induced shape changes, and the mechanisms involved, in cells derived from a model of colon cancer metastasis. Src activity in these cells is associated with formation and dynamic regulation of integrin adhesions and disorganization of E-cadherin-dependent cell-cell contacts. Furthermore, Src-induced deregulation of E-cadherin requires integrin signalling, demonstrating a complex interdependence between integrin- and cadherin-associated adhesion changes induced by Src. The integrin-induced signals that co-operate with Src to cause deregulation of cadherin-dependent cell-cell contacts include activation of the MEK/ERK and MLCK/myosin activities. Inhibition of this pathway suppresses integrin complexes formed on fibronectin, while promoting E-cadherin redistribution to sites of cell-cell contacts. Also, in embryonic fibroblasts that express N-cadherin (which is normally diffusely cytoplasmic as these cells maintain a fibroblastic morphology) suppressing integrin signalling and inhibiting the MEK/ERK/MLCK/myosin pathway relocalizes N-cadherin to cell-cell contacts. Our recent data therefore imply an important, and perhaps general, role for spatially controlled contractility in suppressing normal cadherin localization and inducing a mesenchymal-like phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942195     DOI: 10.1159/000084511

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  25 in total

1.  c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site.

Authors:  Martin Baumgartner; Gerald Radziwill; Mihaela Lorger; Andreas Weiss; Karin Moelling
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

Review 2.  Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon.

Authors:  Ferenc Sipos; Orsolya Galamb
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

3.  Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.

Authors:  Xin Zhang; Ling Su; Ali A Pirani; Haiyan Wu; Hongzheng Zhang; Dong M Shin; Kim M Gernert; Zhuo Georgia Chen
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

Review 4.  The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

Authors:  Christopher Lieu; Scott Kopetz
Journal:  Clin Colorectal Cancer       Date:  2010-04       Impact factor: 4.481

5.  Inhibitors of Src and focal adhesion kinase promote endocrine specification: impact on the derivation of β-cells from human pluripotent stem cells.

Authors:  Ivka Afrikanova; Mayra Yebra; Megan Simpkinson; Yang Xu; Alberto Hayek; Anthony Montgomery
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

Review 6.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 7.  The role of Src in solid tumors.

Authors:  Deric L Wheeler; Mari Iida; Emily F Dunn
Journal:  Oncologist       Date:  2009-07-06

Review 8.  Aquaporin-5: from structure to function and dysfunction in cancer.

Authors:  Inês Direito; Ana Madeira; Maria Alexandra Brito; Graça Soveral
Journal:  Cell Mol Life Sci       Date:  2016-02-02       Impact factor: 9.261

9.  A novel tumor suppressor role of myosin light chain kinase splice variants through downregulation of the TEAD4/CD44 axis.

Authors:  Yen-Ju Huang; Tsung-Chun Lee; Yu-Chen Pai; Been-Ren Lin; Jerrold R Turner; Linda Chia-Hui Yu
Journal:  Carcinogenesis       Date:  2021-07-16       Impact factor: 4.944

10.  Increased levels of active c-Src distinguish invasive from in situ lobular lesions.

Authors:  Donghui Zou; Han-Seung Yoon; Ahmad Anjomshoaa; David Perez; Ryuji Fukuzawa; Parry Guilford; Bostjan Humar
Journal:  Breast Cancer Res       Date:  2009-07-07       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.